Malin Corporation | MLC - Des Atouts





Des Atouts Changement Date
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ALKERMES USD 4.26B 1.77B 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Eurofins Scientific SE EUR 10.99B 399.1M 2025-12
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Lonza CHF 18.97B 164M 2025-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 11.49B 850M 2026-03
Organon & Co USD 13B 129M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Revvity USD 12B 171.82M 2026-03
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03